0.75
+0(+0.00%)
Currency In HKD
Sector
Healthcare
Industry
Asset Management
Employees
18
First IPO Date
May 19, 1997
| Name | Title | Pay | Year Born |
| Mr. Jamie Alexander Gibson | Chief Executive Officer & Executive Director | 10.76M | 1966 |
| Dr. Michael Grant Wyllie BSc, D.Sc., DSc | Co-Founder & Chief Scientific Officer | 1.62M | 1951 |
| Mr. Paul Eric Jones BA, MBA | Investment Director | 0 | 1965 |
| Mr. Yui Fui Wong | Chief Financial Officer | 0 | 1975 |
| Ms. Mei Yan Lui | Company Secretary | 0 | 1975 |
| Prof. John Michael Fitzpatrick FC Urol (SA), FRCS, FRCSGlas, FRCSI, MCh | Chairman of Clinical Scientific Advisory Board | 0 | N/A |
Endurance RP Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in the People's Republic of China, Europe, Hong Kong, and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management and corporate finance services. The company was formerly known as Regent Pacific Group Limited and changed its name to Endurance RP Limited in June 2021. Endurance RP Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.
